You are here: BCU: Her2 Testing in Breast Cancer Management: Comparison of HER2 Assays  

Objectives
  • Using the PathVysionTM FISH assay as the standard, compare the manual and the Automated Cellular Imaging System (ACIS®) IHC methods

Methods
  • All infiltrating breast cancer specimens collected between August 1998 and March 2000 were evaluated by manual IHC with a polyclonal antibody (A0485).

  • The PathVysionTM FISH assay was used to analyze 199 of those specimens.

  • Quantitation of IHC staining by ACIS® was conducted on 189 of the 199 cases analyzed by FISH.

Results

Authors’ Conclusions
“The correlation between FISH and the ACIS® method was statistically higher than that between FISH and the manual method.”

“The present study demonstrates that an image analyzer, such as ACIS®, can be applied to quantitate protein on cell membrane. Compared with the manual immunohistochemical method, there are major benefits of using such an image analyzer to quantitate immunohistochemical staining.”

Research Leader Commentary

It really looks like IHC testing should remain in the purview of central reference laboratories. One of the reasons may be that a number of the large reference laboratories are now using digital image analysis for all of their IHC scoring. Digital image analysis takes some of the guesswork out of the interpretation of these IHC assays. There can be honest disagreement between good pathologists over the difference between a 2+ and a 3+, but a computer can actually read the same slide over and over again and give you the exact same result.

Pathologists actually call up the information on a digital screen to confirm and double check the assay performance. In most of the large studies in which head-to-head comparisons have been done with digital image analysis and FISH for HER2 testing, the concordance rate is about of 90 percent.

The remarkable feature of this type of assay is you can take a slide, score it using the digital assay system, and then read it a hundred years later and get the same answer. It’s really highly reproducible in terms of run-to-run variability, much more than the manual read-out for IHC. Even if you give a good pathologist a test set of slides to read and ask them to re-read the same set some time later, there will be some variability that you can’t control. This instrument removes that type of variability.

Mark Pegram, MD

Page 4 of 4
Previous | Related Publications

 

Table of Contents Top of Page
Table of contents
 
CME Information
Editor’s Note:
Getting It Right
Faculty

Concordance Between Local and Central Laboratory HER2 Testing
- Related publications

Comparison of HER2 Assays
- Related publications
Concordance of HER2 Status Between Primary and Metastatic Lesions
- Related publications
HER2 Status and Response to Trastuzumab
- Related publications
College of American Pathologists
 - Related publications
 
Faculty Disclosures
Home · Contact us
Terms of use and general disclaimer